NEW for 2023: Start-Up Success Article Series
PART 3: PROTECTING YOUR FUTURE INTELLECTUAL PROPERTY
May 31, 2023 – In this next part of our series, legal counsel James J. Cronin III explores another complexity of clinical trial contracting: intellectual property provisions.
PART 2: GDPR COMPLIANCE – IMPROVING YOUR POSITION
March 22, 2023 – How is your company improving its position related to GDPR compliance? In Part 2 of our series, legal counsel James J. Cronin III focuses on the basics of evaluating compliance with the GDPR within the evolving framework of guidelines and court opinions.
PART 1: I’M RESPONSIBLE FOR WHAT? INDEMNIFICATION IN CLINICAL TRIALS
January 25, 2023 – ICE Global Consulting invites you to join us as we embark on a multi-part series discussing key elements leading to study start-up success. In today’s article, legal counsel James J. Cronin III reviews 4 crucial considerations for pharmaceutical sponsors when negotiating site indemnification clauses.
ICE GLOBAL CONSULTING, INC. COMPLETES ACQUISITION OF EPICENTER™ TECHNOLOGY
January 11, 2023 (Raleigh, NC) – ICE Global Consulting, Inc. (ICE Global) announced today that it has entered into an asset purchase agreement to acquire all operating assets related to the Epicenter™ contracts management technology from Journey CTS, LLC. ICE Global’s most recent acquisition further solidifies its technology-driven approach to supporting global site contracting, investigator budgeting, and site payments in the clinical research industry.
ICE GLOBAL CONSULTING, INC. AND CLINISTART, INC. MERGE TO CREATE GLOBAL LEADER OF CLINICAL RESEARCH CONTRACTING & SITE PAYMENT SERVICES
May 5, 2022 – Raleigh, NC-based organizations ICE Global Consulting, Inc. and CliniStart, Inc., both providers of global clinical research contracting, investigator budgeting, and site payment administration services, announced today that CliniStart has merged with and into ICE Global to create a specialized clinical research study start-up organization that strategically focuses on the critical areas of trial initiation and study management administration, which have long been underserved.